PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSO4.L Regulatory News (SO4)

  • There is currently no data for SO4

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CEO

13 Sep 2021 07:00

RNS Number : 4813L
Salt Lake Potash Limited
13 September 2021
 

13 September 2021

 

AIM/ASX Code: SO4

 

SALT LAKE POTASH LIMITED

 

Appointment of CEO

Salt Lake Potash (SO4 or the Company) is pleased to advise that Isak Buitendag has been appointed as Chief Executive Officer (CEO) of the Company, subject to requotation of the Company's securities on the Australian Securities Exchange (ASX). It is a non-board appointment

 

·

Mr Buitendag will be joining from his position as General Manager of Transformation at Kazzinc (69.7% owned by Glencore).

·

Prior to Kazzinc, he was Vice President of Operations and Vice President of Development at Kazchrome, the largest ferrochrome producer in the world.

·

Mr Buitendag has significant experience in Executive roles within the mining industry in Australia, Kazakhstan and Africa, including at BHP and Fortescue.

·

In an Executive capacity he has led teams in project development and minerals processing and has a track record of delivering business turnarounds.

·

The SO4 board believes Mr Buitendag's skills and reputation as a disciplined operator and manager will serve shareholders well and look forward to his leadership bringing the Lake Way Project into a sustainable, profitable operation.

 

"I'm excited to be joining SO4 at such a critical stage of its development and look forward to working with the team to deliver Lake Way and grow the business into a meaningful player in the global SOP market"

Isak Buitendag

 

Appendix A: Terms and Conditions of employment for Mr Buitendag

 

1. Appointment

The company anticipate that the Executive will be appointed as CEO of the Company by no later than 15 November 2021. The Executive's employment pursuant to his Executive Services Agreement is subject to requotation of the Company's securities on the ASX.

2. Term

The Executive's employment will commence on the Commencement Date and will continue for a 12 month period (Initial Term) unless terminated by the company or Mr Buitendag.

3. Probation Period

The employment is subject to satisfactory completion of a 3 month probationary period.

4. Remuneration

The remuneration package offered to Mr Buitendag is designed to link reward to both Company and individual performance, and to align his interests with the interests of shareholders. The remuneration package comprises the following components:

·

Cash Salary Component of A$400,000 (exclusive of superannuation)

 

·

Short Term Incentive (STI) Component to be determined by the Board after consultation with the Executive for FY23 taking into account comparable market information.

 

·

Long Term Incentive (LTI) Component to be determined by the Board after consultation with the Executive for FY23 taking into account comparable market information.

 

·

Sign on Bonus Component, performance rights to be issued under and in accordance with the Performance Right Plan.

 

 

Number

 

Milestone

2.5 million

Upon completion of 3 months employment

2.5 million

Upon successful production and sale of budgeted SOP by 30 June 2022

2.5 million

Upon successful production and sale of budgeted SOP for calendar year ended 2022

 

5. Termination and Notice

Mr Buitendag's employment agreement may be terminated in the following circumstances.

· Resignation by Mr Buitendag on 3 months written notice

· Termination by the Company on 3 months written notice or by making payment in lieu of notice.

· Termination by the Company without notice for serious misconduct or other circumstances justifying summary dismissal.

On termination of his Executive Services Agreement, the Executive will be entitled to receive from the Company all payments owed to him under this Agreement up to and including the date of termination and any payments due to him pursuant to any relevant legislation by way of accrued annual leave and long service leave.

Any entitlements held under the Company's LTI and STI plans will be treated (and may be retained or forfeited) in accordance with applicable plan rules.

 

 

Tony Swiericzuk / Richard Knights

Salt Lake Potash Limited

Tel: +61 8 6559 5800

Colin Aaronson / Lukas Girzadas

Grant Thornton UK LLP (Nominated Adviser)

Tel: +44 (0) 20 7383 5100

Derrick Lee / Peter Lynch

Cenkos Securities plc (Broker)

Tel: +44 (0) 131 220 6939

 

This announcement has been authorised for release by the Board of Directors.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUUUBUPGUBP
Date   Source Headline
20th Jun 201910:23 amRNSHolding(s) in Company
19th Jun 20197:25 amRNSCompany Presentation
18th Jun 20191:45 pmRNSHolding(s) in Company
18th Jun 20191:45 pmRNSHolding(s) in Company
18th Jun 20197:00 amRNSAppendix 3B and Additional Issue of Shares
14th Jun 20197:27 amRNSAppendix 3B and Issue of Placement Shares
13th Jun 20197:00 amRNSResults of Scoping Study at Lake Way
6th Jun 20194:41 pmRNSSecond Price Monitoring Extn
6th Jun 20194:35 pmRNSPrice Monitoring Extension
6th Jun 20197:00 amRNSStrategic Placement to Fund Lake Way Development
5th Jun 20197:00 amRNSASX Trading Halt
15th May 20199:41 amRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSMarch 2019 Appendix 5B
30th Apr 20197:00 amRNSMarch 2019 Quarterly Report
18th Apr 20192:00 pmRNSAppointment of Joint Broker
8th Apr 20197:00 amRNSSalt Lake Potash and Blackham Resources Agreement
25th Mar 20197:00 amRNSCompany Presentation
18th Mar 20197:00 amRNSSOP Resource Delineated at Lake Way
14th Mar 20197:00 amRNSHalf-year Report
6th Mar 20197:00 amRNSConstruction Begins on SOP Evaporation Ponds
5th Mar 20192:38 pmRNSHolding(s) in Company
8th Feb 20197:07 amRNSChange of Registered Office
31st Jan 20197:00 amRNSDecember 2018 Appendix 5B
31st Jan 20197:00 amRNSDecember 2018 Quarterly Report
29th Jan 20197:00 amRNSLake Way Field Trials Confirm Salt Prod'n Process
14th Jan 201912:30 pmRNSHolding(s) in Company
9th Jan 20197:00 amRNSCompletion of Placement and Directors' Holdings
31st Dec 20187:00 amRNSAppendix 3Y Change of Director's Interest Notices
31st Dec 20187:00 amRNSIssue of Ordinary Shares and Appendix 3B
20th Dec 20187:00 amRNSResults of General Meeting
13th Dec 20189:55 amRNSGovernment Support for Potash Industry Development
10th Dec 20187:00 amRNSNative Title Land Access and Exploration Agreement
7th Dec 201811:05 amRNSHolding(s) in Company
6th Dec 20187:00 amRNSSalt Lake Enhances Senior Project Development Team
30th Nov 20188:21 amRNSResults of Annual General Meeting
20th Nov 20187:00 amRNSCompletion of First Tranche of Placement
19th Nov 20183:32 pmRNSHolding(s) in Company
19th Nov 20187:00 amRNSStatement Regarding Online Article
16th Nov 20183:11 pmRNSAdmission of Placement Shares
16th Nov 20188:36 amRNSAppendix 3B
9th Nov 20187:00 amRNSA$13.0 Million Placement
7th Nov 20187:00 amRNSASX Trading Halt
5th Nov 20187:00 amRNSAppointment of Managing Director and CEO
2nd Nov 20187:06 amRNSAppendix 3B
31st Oct 20188:46 amRNSNotice of AGM
31st Oct 20187:00 amRNSSeptember 2018 Quarterly Report
31st Oct 20187:00 amRNSSeptember 2018 Appendix 5B
22nd Oct 20187:00 amRNSAppointment of Managing Director & CEO
19th Oct 20187:00 amRNSASX Trading Halt
8th Oct 20187:00 amRNSApproval to Construct Williamson Ponds at Lake Way

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.